It was initially approved based on pharmacokinetic studies demonstrating bioequivalence with Sinemet® immediate release (IR; levodopa/carbidopa) plus entacapone administered as separate tablets.

Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications. Mounting evidence ...

As a result, the most common and effective treatment of motor symptoms related to Parkinson’s disease is a combination of the drugs levodopa and carbidopa. This drug combination, sometimes ...

compared to oral immediate-release carbidopa/levodopa. The drug’s progress in the US was held up earlier this year by a complete response letter (CRL) from the FDA seeking more information about ...

Carbidopa 37.5mg, levodopa 150mg, entacapone 200mg; tabs. Swallow whole; max one tablet per dosing interval. Previously on carbidopa/levodopa and entacapone: substitute on a mg/mg basis.

Carbidopa 25mg, levodopa 100mg, entacapone 200mg; tabs. Swallow whole; max one tablet per dosing interval. Previously on carbidopa/levodopa and entacapone: substitute on a mg/mg basis. Stalevo 50 ...

Get detailed information on Levodopa, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...